Related Experiment Video
Updated: May 8, 2025

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
Review of Applications of Microneedling in Melasma
Wenwen Chen1, Xingling Jian2, Bo Yu2
1Department of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Background:
Melasma, a common skin pigmentation disease, can negatively impact patients' mental health, social interactions, and physical appearance. Although we now have several treatments accessible, such as medicines, chemical peels, and phototherapy, which can help ease symptoms to some extent, the requirement for a long-term effective and safe treatment for patients is far from met. In the face of this problem, microneedling, as an innovative treatment, provides a new avenue for treating melasma. Although microneedling has been extensively investigated for treating other skin issues such as inflammation, scarring, and photoaging, research into its use in melasma treatment is still in its early stages.
Objective:
This study aimed to gather and assess clinical information on microneedling's effectiveness in treating melasma, covering research gaps and serving as a beneficial reference for clinical therapy.
Methods:
We searched PubMed, Cochrane, Scopus, Embase, and Web of Science databases for articles with the keywords "microneedling," "percutaneous collagen induction", and "melasma." Following a thorough assessment, we selected 64 clinical studies that matched the requirements for in-depth analysis.
Results:
After thoroughly reviewing these data, we concluded that microneedling has tremendous potential for treating melasma. Microneedling can significantly improve treatment outcomes, especially when paired with additional therapies such as topical medicines or phototherapy.
Conclusion:
Overall, the evidence reported in this study demonstrates that microneedling is an essential advancement in melasma treatment. Not only can it improve the efficacy of topical drugs and other treatment modalities, but it also has an excellent safety and tolerability profile, making it desirable to patients and clinicians. While the current findings are encouraging, more study is needed to refine treatment protocols, investigate the long-term consequences of microneedling, and establish it as the standard of care for melasma treatment. We anticipate that microneedling will play an increasingly important role in the future of melasma treatment, providing our patients with more hope and a broader choice of treatment alternatives.
Insights
Microneedling shows great potential for treating melasma, significantly improving outcomes, especially with combination therapies. Further research is needed to establish microneedling as a standard melasma treatment.
Area of Science:
- Dermatology
- Aesthetic Medicine
Background:
- Melasma significantly impacts patient quality of life.
- Current melasma treatments offer limited long-term efficacy.
- Microneedling is an emerging treatment for melasma.
Purpose of the Study:
- To evaluate the clinical effectiveness of microneedling for melasma treatment.
- To identify research gaps in microneedling for melasma.
- To provide a reference for clinical application of microneedling in melasma.
Main Methods:
- Systematic literature search across major databases (PubMed, Cochrane, Scopus, Embase, Web of Science).
- Keywords used: "microneedling," "percutaneous collagen induction," and "melasma."
- Analysis of 64 selected clinical studies.
Main Results:
- Microneedling demonstrates significant potential in melasma treatment.
- Combination therapy (microneedling with topical agents or phototherapy) enhances outcomes.
- Microneedling shows a favorable safety and tolerability profile.
Conclusions:
- Microneedling represents a significant advancement in melasma therapy.
- It improves the efficacy of existing treatments and offers a safe option.
- Further research is required to optimize protocols and confirm long-term efficacy.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

